Home   Site Map   About Roche   Contact Us   Help   
This is a alt text for OsteoporosisThis is a alt text for Osteoporosis
Clinical. Credible. Convenient.
Not a Member? Log In Forgot Password? Instant Access Code
Sign Up
»
 E-mail: Password: Code:
  Remember Me Log In
»
 Go
»
Main Menu
Osteoporosis Home
News
Clinical Trials
Education
Publications
Other Resources
Meeting Calendar

Select a link below to view details.
Previous March 2010 Next
S M T W T F S
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      
Osteoporosis Publications

Display by:    Publication date     Author     Alphabetical by Publication Title  
  Richard Derman, Joseph D Kohles, Ann Babbitt
infotrieve.gif Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
Clinical Interventions in Aging 2009 4(): 357 - 365
 
  Binkley et al
infotrieve.gif Improved GI Tolerability with Monthly Ibandronate in Women Previously Using Weekly Bisphosphonates
Southern Medical Journal 2009 102(492): 5 - 486
 
  Harris, Reginster, Harley, Blumentals, Poston, Barr, Silverman
infotrieve.gif Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: The eValuation of Ibandronate Efficacy (VIBE) database fracture study
Bone 2009 doi: 10.1016(j.bone.2009.01.002): -
 
  Willliam A Blumentals, Stuart Silverman et al
infotrieve.gif Risk of Severe Gastrointestinal Events in Women Treated with Monthly Ibandronate or Weekly Alendronate
Annals of Pharmacotherapy 2009 43(): 577 - 585
 
  Bonnick SL, Civitelli R, et al
infotrieve.gif Patient Satisfaction in Postmenopausal Women Treated with a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate
Journal of Women’s Health 2009 18(7): 935 - 943
 
  Ronald Emkey et al
infotrieve.gif Efficacy and Tolerability of Once Monthly Oral Ibandronate (150 mg) and Once Weekly Oral Alendronate (70mg): Additional Results From the Monthly Oral Therapy With Ibandronate for Osteoporosis Intervention (MOTION) Study
Clinical Therapeutics 2009 31(4): 751 - 761
 
  Raymond E. Cole DO, Steven T. Harris MD
infotrieve.gif Preventing Nonvertebral Osteoporotic Fractures With Extended-Inter Bisphosphonates: Regimen Selection and Clinical Application
Medscape J Med 2009 11(1): 12 -
 
  John A. Eisman, Robert R. Recker, Eisman et al
infotrieve.gif Efficacy and Tolerability of Intravenous Ibandronate Injections in Postmenopausal Osteoporosis: 2 Year Results from the DIVA Study
J Rheumatol 2008 35(3): 488 - 497
 
  A. Cranney
infotrieve.gif Ibandronate for the Prevention of Nonvertebral Fractures: A Pooled Analysis of Individual Patient Data
Osteoporosis International 2008 Epub(): DOI 10.1007 - s00198-008-0653-8
 
  Michael Lewiecki
infotrieve.gif Once Monthly Oral Ibandronate Improves Biomechanical Determinants of Bone Strength in Women With Postmenopausal Osteoporosis
J Clin Endocrin Metab 2008 Epub(): doi:10.1210/jc.2008- -